Literature DB >> 30673299

The MRI characteristics of non-mass enhancement lesions of the breast: associations with malignancy.

Hale Aydin1.   

Abstract

OBJECTIVE: : The American College of Radiology updated the terms used for expressing the imaging characteristics of non-mass enhancement (NME) lesions in the fifth edition of the breast imaging-reporting data system (BI-RADS) lexicon. Both the distribution and internal enhancement descriptors were revised for NME lesions. Our aim was to determine the MRI characteristics of NME lesions and to investigate their association with malignancy.
METHODS: : The MRI results of 129 NME lesions were retrospectively evaluated. The medical files, biopsy results and follow-up findings of lesions were recorded. Patients who had benign biopsy and those who had stable or regressed lesions during follow-up were classified as benign. All MRI results had been obtained with a 1.5 Tesla Signa HDx MR system (GE Healthcare).
RESULTS: : Segmental and diffuse distribution along with clustered-ring internal enhancement were significantly associated with malignancy, while linear distribution and homogeneous enhancement pattern were associated with benignancy. Additionally, the plateau type (Type II) curve was significantly more frequent in malignant lesions. There was no association between the presence of cystic structures and the benign/malignant nature of the lesion. However, multivariate logistic regression showed that only segmental distribution and diffusion restriction were associated with malignancy.
CONCLUSION: : In the current study, segmental distribution, clustered-ring enhancement, Type II dynamic curve and the presence of diffusion restriction were found to be associated with malignancy. There is a requirement for multicenter studies which include higher numbers of patients in order to better evaluate lesions with rarer characteristics for distribution and enhancement pattern. ADVANCES IN KNOWLEDGE:: Our aim in this study was to investigate the MRI characteristics of NME lesions. We have reported the MRI findings of NME lesions and have found that segmental distribution and clustered-ring enhancement patterns are significantly more frequent in malignant lesions.

Entities:  

Mesh:

Year:  2019        PMID: 30673299      PMCID: PMC6540851          DOI: 10.1259/bjr.20180464

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  29 in total

1.  High-spatial-resolution MRI of non-masslike breast lesions: interpretation model based on BI-RADS MRI descriptors.

Authors:  Mitsuhiro Tozaki; Kunihiko Fukuda
Journal:  AJR Am J Roentgenol       Date:  2006-08       Impact factor: 3.959

2.  Breast MRI using the VIBE sequence: clustered ring enhancement in the differential diagnosis of lesions showing non-masslike enhancement.

Authors:  Mitsuhiro Tozaki; Takao Igarashi; Kunihiko Fukuda
Journal:  AJR Am J Roentgenol       Date:  2006-08       Impact factor: 3.959

3.  Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.

Authors:  Mitchell D Schnall; Jeffrey Blume; David A Bluemke; Gia A DeAngelis; Nanette DeBruhl; Steven Harms; Sylvia H Heywang-Köbrunner; Nola Hylton; Christiane K Kuhl; Etta D Pisano; Petrina Causer; Stuart J Schnitt; David Thickman; Carol B Stelling; Paul T Weatherall; Constance Lehman; Constantine A Gatsonis
Journal:  Radiology       Date:  2006-01       Impact factor: 11.105

Review 4.  The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice.

Authors:  Christiane Kuhl
Journal:  Radiology       Date:  2007-08       Impact factor: 11.105

5.  Segmental enhancement on breast MR images: differential diagnosis and diagnostic strategy.

Authors:  Sachiko Yuen; Takayoshi Uematsu; Kasami Masako; Yoshihiro Uchida; Tsunehiko Nishimura
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

6.  Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI.

Authors:  N Morakkabati-Spitz; C Leutner; H Schild; F Traeber; C Kuhl
Journal:  Eur Radiol       Date:  2005-04-20       Impact factor: 5.315

7.  Magnetic resonance imaging of the breast prior to biopsy.

Authors:  David A Bluemke; Constantine A Gatsonis; Mei Hsiu Chen; Gia A DeAngelis; Nanette DeBruhl; Steven Harms; Sylvia H Heywang-Köbrunner; Nola Hylton; Christiane K Kuhl; Constance Lehman; Etta D Pisano; Petrina Causer; Stuart J Schnitt; Stanley F Smazal; Carol B Stelling; Paul T Weatherall; Mitchell D Schnall
Journal:  JAMA       Date:  2004-12-08       Impact factor: 56.272

8.  Nonpalpable mammographically occult invasive breast cancers detected by MRI.

Authors:  Lia Bartella; Laura Liberman; Elizabeth A Morris; D David Dershaw
Journal:  AJR Am J Roentgenol       Date:  2006-03       Impact factor: 3.959

9.  Categorization of non-mass-like breast lesions detected by MRI.

Authors:  Naomi Sakamoto; Mitsuhiro Tozaki; Kuniki Higa; Yuko Tsunoda; Tomoko Ogawa; Satoko Abe; Shinji Ozaki; Masaaki Sakamoto; Tomoko Tsuruhara; Naoko Kawano; Takako Suzuki; Norie Yamashiro; Eisuke Fukuma
Journal:  Breast Cancer       Date:  2008-01-22       Impact factor: 4.239

10.  Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria.

Authors:  B K Szabó; P Aspelin; M Kristoffersen Wiberg; B Boné
Journal:  Acta Radiol       Date:  2003-07       Impact factor: 1.701

View more
  7 in total

1.  Management of Non-Mass Enhancement at Breast Magnetic Resonance in Screening Settings Referred for Magnetic Resonance-Guided Biopsy.

Authors:  Eduardo de Faria Castro Fleury; Caio Castro; Mario Sergio Campos do Amaral; Décio Roveda Junior
Journal:  Breast Cancer (Auckl)       Date:  2022-05-16

2.  Differentiation between Clinically Noninflammatory Granulomatous Lobular Mastitis and Noncalcified Ductal Carcinoma in situ Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Authors:  Ning Qu; Yahong Luo; Tao Yu
Journal:  Breast Care (Basel)       Date:  2020-02-25       Impact factor: 2.860

3.  Comparison of Diagnostic Efficacy Between Contrast-Enhanced Ultrasound and DCE-MRI for Mass- and Non-Mass-Like Enhancement Types in Breast Lesions.

Authors:  Wei Liu; Min Zong; Hai-Yan Gong; Li-Jun Ling; Xin-Hua Ye; Shui Wang; Cui-Ying Li
Journal:  Cancer Manag Res       Date:  2020-12-31       Impact factor: 3.989

4.  BI-RADS Reading of Non-Mass Lesions on DCE-MRI and Differential Diagnosis Performed by Radiomics and Deep Learning.

Authors:  Jiejie Zhou; Yan-Lin Liu; Yang Zhang; Jeon-Hor Chen; Freddie J Combs; Ritesh Parajuli; Rita S Mehta; Huiru Liu; Zhongwei Chen; Youfan Zhao; Zhifang Pan; Meihao Wang; Risheng Yu; Min-Ying Su
Journal:  Front Oncol       Date:  2021-11-01       Impact factor: 6.244

5.  Non-Mass Enhancements on DCE-MRI: Development and Validation of a Radiomics-Based Signature for Breast Cancer Diagnoses.

Authors:  Yan Li; Zhenlu L Yang; Wenzhi Z Lv; Yanjin J Qin; Caili L Tang; Xu Yan; Yihao H Guo; Liming M Xia; Tao Ai
Journal:  Front Oncol       Date:  2021-09-22       Impact factor: 6.244

6.  Non-mass enhancement breast lesions: MRI findings and associations with malignancy.

Authors:  Gang Liu; Ying Li; Si-Lu Chen; Qiao Chen
Journal:  Ann Transl Med       Date:  2022-03

7.  LINC00662 enhances cell progression and stemness in breast cancer by MiR-144-3p/SOX2 axis.

Authors:  Congjing An; Zhigang Hu; Yuehong Li; Pengxin Zhao; Runtian Liu; Qing Zhang; Peiling Zhu; Yanting Li; Ying Wang
Journal:  Cancer Cell Int       Date:  2022-05-12       Impact factor: 6.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.